124 related articles for article (PubMed ID: 24531782)
1. Aspirin and prostate cancer prevention.
Bosetti C; Rosato V; Gallus S; La Vecchia C
Recent Results Cancer Res; 2014; 202():93-100. PubMed ID: 24531782
[TBL] [Abstract][Full Text] [Related]
2. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.
Jacobs EJ; Rodriguez C; Mondul AM; Connell CJ; Henley SJ; Calle EE; Thun MJ
J Natl Cancer Inst; 2005 Jul; 97(13):975-80. PubMed ID: 15998950
[TBL] [Abstract][Full Text] [Related]
3. Aspirin and cancer risk: an updated quantitative review to 2005.
Bosetti C; Gallus S; La Vecchia C
Cancer Causes Control; 2006 Sep; 17(7):871-88. PubMed ID: 16841255
[TBL] [Abstract][Full Text] [Related]
4. Regular use of aspirin and prostate cancer risk (United States).
Menezes RJ; Swede H; Niles R; Moysich KB
Cancer Causes Control; 2006 Apr; 17(3):251-6. PubMed ID: 16489532
[TBL] [Abstract][Full Text] [Related]
5. A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence.
Jacobs EJ; Thun MJ; Bain EB; Rodriguez C; Henley SJ; Calle EE
J Natl Cancer Inst; 2007 Apr; 99(8):608-15. PubMed ID: 17440162
[TBL] [Abstract][Full Text] [Related]
6. Aspirin use in relation to risk of prostate cancer.
Leitzmann MF; Stampfer MJ; Ma J; Chan JM; Colditz GA; Willett WC; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1108-11. PubMed ID: 12376516
[TBL] [Abstract][Full Text] [Related]
7. Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer.
Perron L; Bairati I; Moore L; Meyer F
Int J Cancer; 2003 Sep; 106(3):409-15. PubMed ID: 12845682
[TBL] [Abstract][Full Text] [Related]
8. Non-steroidal anti-inflammatory drug use and prostate cancer in a high-risk population.
Mahmud SM; Tanguay S; Bégin LR; Franco EL; Aprikian AG
Eur J Cancer Prev; 2006 Apr; 15(2):158-64. PubMed ID: 16523013
[TBL] [Abstract][Full Text] [Related]
9. Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.
Platz EA; Rohrmann S; Pearson JD; Corrada MM; Watson DJ; De Marzo AM; Landis PK; Metter EJ; Carter HB
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):390-6. PubMed ID: 15734963
[TBL] [Abstract][Full Text] [Related]
10. Maintenance use of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk.
Ma Y; Brusselaers N
Prostate Cancer Prostatic Dis; 2018 Apr; 21(1):147-152. PubMed ID: 29259292
[TBL] [Abstract][Full Text] [Related]
11. Use of non-steroidal anti-inflammatory drugs and prostate cancer survival in the Finnish prostate cancer screening trial.
Veitonmäki T; Murtola TJ; Määttänen L; Taari K; Stenman UH; Tammela TL; Auvinen A
Prostate; 2015 Sep; 75(13):1394-402. PubMed ID: 26073992
[TBL] [Abstract][Full Text] [Related]
12. Incident cancer risk after the start of aspirin use: results from a Dutch population-based cohort study of low dose aspirin users.
Hollestein LM; van Herk-Sukel MP; Ruiter R; de Vries E; Mathijssen RH; Wiemer EA; Stijnen T; Coebergh JW; Lemmens VE; Herings RM; Stricker BH; Nijsten T
Int J Cancer; 2014 Jul; 135(1):157-65. PubMed ID: 24285345
[TBL] [Abstract][Full Text] [Related]
13. Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis.
González-Pérez A; García Rodríguez LA; López-Ridaura R
BMC Cancer; 2003 Oct; 3():28. PubMed ID: 14588079
[TBL] [Abstract][Full Text] [Related]
14. Aspirin and nonsteroidal anti-inflammatory drug use and risk of pancreatic cancer: a meta-analysis.
Larsson SC; Giovannucci E; Bergkvist L; Wolk A
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2561-4. PubMed ID: 17164387
[TBL] [Abstract][Full Text] [Related]
15. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
Moyad MA
Semin Urol Oncol; 2001 Nov; 19(4):306-16. PubMed ID: 11769882
[TBL] [Abstract][Full Text] [Related]
16. Aspirin use and the risk of prostate cancer: a meta-analysis of 24 epidemiologic studies.
Huang TB; Yan Y; Guo ZF; Zhang XL; Liu H; Geng J; Yao XD; Zheng JH
Int Urol Nephrol; 2014 Sep; 46(9):1715-28. PubMed ID: 24687637
[TBL] [Abstract][Full Text] [Related]
17. Do Aspirin and Other NSAIDs Confer a Survival Benefit in Men Diagnosed with Prostate Cancer? A Pooled Analysis of NIH-AARP and PLCO Cohorts.
Zhou CK; Daugherty SE; Liao LM; Freedman ND; Abnet CC; Pfeiffer R; Cook MB
Cancer Prev Res (Phila); 2017 Jul; 10(7):410-420. PubMed ID: 28507039
[TBL] [Abstract][Full Text] [Related]
18. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
Sandler RS
Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
[TBL] [Abstract][Full Text] [Related]
19. Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies.
Qiao Y; Yang T; Gan Y; Li W; Wang C; Gong Y; Lu Z
BMC Cancer; 2018 Mar; 18(1):288. PubMed ID: 29534696
[TBL] [Abstract][Full Text] [Related]
20. Aspirin and urologic cancer risk: an update.
Bosetti C; Rosato V; Gallus S; La Vecchia C
Nat Rev Urol; 2012 Jan; 9(2):102-10. PubMed ID: 22270135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
